Stock futures maintained their gains on Friday as traders digested the latest labor data and pared some bets about the Fed's policy easing.
Here are some of Friday's biggest stock movers:
Biggest stock gainers
GCT Semiconductor (GCTS) shares soared 44% after the company announced a partnership with Aramco (ARMCO) to enhance the 4G/5G ecosystem in Saudi Arabia, boosting mission-critical networks.
2seventy bio (TSVT) shares climbed 13% after the company and Bristol Myers Squibb (BMY) received U.S. FDA approval for Abecma in the treatment of adult patients with relapsed or refractory multiple myeloma.
AngioDynamics (ANGO) shares surged 7% after Oppenheimer upgraded the medical device maker to Outperform from Perform, citing the FDA's recent decision to expand the use of its AlphaVac F1885 medical device.
Krispy Kreme's (DNUT) shares were up 6% after trading in red in the days following the announcement of its relationship with McDonald's (MCD). Piper Sandler believes the news is a "game changer" for Krispy Kreme (DNUT) and will boost the company's narrative from here, according to Piper Sandler analyst Brian Mullan.
Grindrod Shipping Holdings (GRIN) shares climbed 27% after the company disclosed its plans for a selective capital reduction, which will involve lowering its issued share capital from ~$290 million comprised of 19,685,590 shares to ~$240 million comprised of 16,206,365 shares.
Biggest stock losers
Altice USA (ATUS) shares dropped more than 9% as Wells Fargo cut its estimates and downgraded the cable provider, citing worries over increased competition from fiber.
More on related stocks:
Krispy Kreme's partnership with McDonald's a 'game changer' for the business -analyst
Altice slips as Wells Fargo cuts estimates, downgrades amid fiber competition worries
Grindrod Shipping to seek shareholder OK for selective capital reduction
Bristol Myers, 2seventy bio receive FDA approval for Abecma to treat multiple myeloma